Wybierz wielkość
| Gabaryty przesyłki | SKU | Dostępność | Cena netto |
|---|---|---|---|
| 250 g | Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności | 203,00 zł | |
| 1 kg | Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności | 594,00 zł |
Informacje o tej pozycji
203,00 zł
Quality Level
form
solid
potency
2500 mg/kg LD50, oral (Rat)
mp
38-42 °C
transition temp
flash point >149 °C
storage temp.
2-30°C
SMILES string
O(CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCCCCCCCCCCCCCCC)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCO
InChI
1S/C56H114O21/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-17-58-19-21-60-23-25-62-27-29-64-31-33-66-35-37-68-39-41-70-43-45-72-47-49-74-51-53-76-55-56-77-54-52-75-50-48-73-46-44-71-42-40-69-38-36-67-34-32-65-30-28-63-26-24-61-22-20-59-18-16-57/h57H,2-56H2,1H3
InChI key
NLMKTBGFQGKQEV-UHFFFAOYSA-N
Application
- Potential Activity of Micafungin and Amphotericin B Co-Encapsulated in Nanoemulsion against Systemic Candida auris Infection in a Mice Model.: This study investigates the use of Brij® 58 in formulating a nanoemulsion to enhance the efficacy of micafungin and amphotericin B against systemic Candida auris infections in mice. The results suggest significant improvements in drug delivery and antifungal activity (Marena et al., 2024).
- Encapsulation of Pure Water-Stable Perovskite Nanocrystals (PNCs) into Biological Environment-Stable PNCs for Cell Imaging.: This research highlights the role of Brij® 58 in stabilizing perovskite nanocrystals, enhancing their stability and applicability in biological environments for cell imaging purposes (Zheng et al., 2024).
- Improving Drug Delivery on Candida Albicans Using Geraniol Nanoemulsion.: This paper discusses the use of Brij® 58 in geraniol nanoemulsions to enhance drug delivery against Candida albicans, showing improved antifungal effectiveness and stability (Silva Pontes et al., 2023).
- Combined Effect of Shaking Orbit and Vial Orientation on the Agitation-Induced Aggregation of Proteins.: Brij® 58 is utilized in this study to prevent protein aggregation in pharmaceutical formulations during agitation, highlighting its importance in maintaining protein stability (Dasnoy et al., 2024).
Analysis Note
Water (K. F.): ≤ 3.0 %
Due to its specific melting range the product may be solid, liquid, a solidified melt or a supercooled melt.
Legal Information
1 of 1
Ta pozycja | |||
|---|---|---|---|
| form solid | form solid | form - | form pellets |
| storage temp. 2-30°C | storage temp. 2-30°C | storage temp. - | storage temp. - |
| Quality Level 200 | Quality Level 200 | Quality Level 200 | Quality Level 200 |
| mp 38-42 °C | mp - | mp - | mp 39-43 °C |
| potency 2500 mg/kg LD50, oral (Rat) | potency >78000 mg/kg LD50, oral (Rat) | potency - | potency - |
| transition temp flash point >149 °C | transition temp flash point >149 °C | transition temp - | transition temp - |
hcodes
pcodes
Hazard Classifications
Aquatic Chronic 2
Klasa składowania
11 - Combustible Solids
wgk
WGK 2
flash_point_f
302.0 °F - closed cup
flash_point_c
150 °C - closed cup
Certyfikaty analizy (CoA)
Poszukaj Certyfikaty analizy (CoA), wpisując numer partii/serii produktów. Numery serii i partii można znaleźć na etykiecie produktu po słowach „seria” lub „partia”.
Masz już ten produkt?
Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.
Numer pozycji handlu globalnego
| SKU | NUMER GTIN |
|---|---|
| 8147270250 | 04022536422756 |
| 8147271000 | 04022536422763 |



